Patients with type 1 diabetes often have sub-optimal glycemic control. The gold standard of treatment is basal-bolus insulin or continuous subcutaneous insulin infusion via an insulin pump. However, only a third of patients with type 1 diabetes achieve the American Diabetes Association A1C goal
Semaglutide for CKD – Does the FLOW trial impact the standard of care?
“We’ed” Better Work Together to Address Cannabis Use in Pregnancy
Remote Patient Monitoring (RPM): The Promise and Pitfalls
An Age-Old Question: Warfarin or a Direct Oral Anticoagulant in Frail Adults?
Complex Patient Case 6: Multiple Comorbidities and Too Many Meds
Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs
Managing COPD: 2024 GOLD Guideline Updates and More
Conquering Confusion: Could Metformin Reduce Dementia Risk?
Complex Patient Case 5: Hypoglycemia and a Painful, Swollen Leg
Top Ten Things Every Clinician Should Know About Pharmacogenomics
Driving + Older Adult + Medications = An Accident Waiting to Happen?
Eosinophils Take the Wheel in Steering Steroid Therapy for COPD Exacerbations
SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Treating Depression and Anxiety: Dosing, Pharmacogenetics, and Our Learners
Complex Patient Case 4: Diabetes, CKD, and Psoriasis
Can Losing Weight Using Semaglutide Prevent a Heart Attack, Ack, Ack, Ack, Ack?
Prescription for Savings: The Clinical and Economic Impact of Pharmacist-Led Hypertension Management in the U.S.
Heartburn Headache: Cumulative PPI Use and Dementia Risk
Does Size Matter? The Surprising Impact of Cuff Size on Blood Pressure Readings
Defining the Role of Semaglutide in Obese Patients with Heart Failure with Preserved Ejection Fraction
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive